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Background: The vaginal microbiome plays an important role in urogenital health. Quantitative real time
Polymerase Chain Reaction (qPCR) assays for the most prevalent vaginal Lactobacillus species and bacterial vaginosis
species G. vaginalis and A. vaginae exist, but qPCR information regarding variation over time is still very limited. We
set up qPCR assays for a selection of seven species and defined the temporal variation over three menstrual cycles
in a healthy Caucasian population with a normal Nugent score. We also explored differences in qPCR data between
these healthy women and an ‘at risk’ clinic population of Caucasian, African and Asian women with and without
bacterial vaginosis (BV), as defined by the Nugent score.
Results: Temporal stability of the Lactobacillus species counts was high with L. crispatus counts of 108 copies/mL
and L. vaginalis counts of 106 copies/mL. We identified 2 types of ‘normal flora’ and one ‘BV type flora’ with latent
class analysis on the combined data of all women. The first group was particularly common in women with a
normal Nugent score and was characterized by a high frequency of L. crispatus, L. iners, L. jensenii, and L. vaginalis
and a correspondingly low frequency of L. gasseri and A. vaginae. The second group was characterized by the
predominance of L. gasseri and L. vaginalis and was found most commonly in healthy Caucasian women. The third
group was commonest in women with a high Nugent score but was also seen in a subset of African and Asian
women with a low Nugent score and was characterized by the absence of Lactobacillus species (except for L. iners)
but the presence of G. vaginalis and A. vaginae.
Conclusions: We have shown that the quantification of specific bacteria by qPCR contributes to a better
description of the non-BV vaginal microbiome, but we also demonstrated that differences in populations such as
risk and ethnicity also have to be taken into account. We believe that our selection of indicator organisms
represents a feasible strategy for the assessment of the vaginal microbiome and could be useful for monitoring the
microbiome in safety trials of vaginal products.Background
The resident Lactobacillus species are the dominant
constituents of the healthy vaginal microbiome and play
an important role in the defense against sexually trans-
mitted infections (STIs) and HIV [1-3]. Lactobacilli
comprise part of the larger innate and adaptive mucosal
immune system of the female lower genital tract [4].
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reproduction in any medium, provided the oraddition to the production of lactic acid and the creation
of a hostile acid environment, Lactobacillus species pro-
ducing H2O2 have been shown to inhibit the growth of
various micro-organisms, including HIV in vitro [5,6].
Bacterial vaginosis (BV), defined as the colonization of
the vagina by several types of anaerobes, including Gard-
nerella vaginalis, together with a reduction in Lactoba-
cillus species, has been associated with increased
susceptibility to STI and HIV acquisition in both epi-
demiological studies and in vitro assays [3,6,7].
The findings that alterations in the vaginal micro-
biome can be associated with negative health outcomesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the microbiome during trials of vaginal products. The
Nugent score is a quick and cheap microscopic tool to
assess the presence of Lactobacillus species, G. vaginalis,
Bacteroides spp. and curved Gram-negative bacilli [8].
Currently this method is considered to be the gold
standard for the diagnosis of BV and has been very use-
ful in research but it does not provide reliable identifica-
tion and quantification of the bacteria at the species
level. Molecular techniques based on the amplification
of the 16 S ribosomal RNA and 16 S-23 S ribosomal
RNA genes from resident bacteria have made it possible
to detect and quantify both cultivable and cultivation re-
sistant organisms at the species level [9-11]. Using quan-
titative real time Polymerase Chain Reaction (qPCR)
assays with primers targeting species specific 16 S ribo-
somal DNA regions, it has been confirmed that a healthy
microbiome is dominated by several Lactobacillus spe-
cies [12-15]. Recent pyrosequencing studies suggest that
there are a variety of ‘healthy’ microbiomes in the
human vagina [14,16]. Ravel et al. proposed five micro-
biome groups (I to V) in asymptomatic women in the
US, distinguishable both by the dominance of Lactoba-
cillus species and by the presence of a particular Lacto-
bacillus species [14]. Communities in group I are
dominated by L. crispatus, whereas communities in
group II, III, and V are dominated by L. gasseri, L. iners,
and L. jensenii, respectively. Communities in group IV
are the most diverse and have a higher proportion of
strictly anaerobic bacteria in combination with Lactoba-
cillus species. Although all five bacterial communities
were found in these asymptomatic women, higher
Nugent scores were mostly associated with those in
group IV.
We set up qPCR assays for the monitoring of the va-
ginal microbiome during clinical trials of vaginal pro-
ducts based on the following indicator organisms:
Lactobacillus genus, L. crispatus, L. iners, L. jensenii, L.
gasseri, L. vaginalis, Gardnerella vaginalis and Atopo-
bium vaginae. Our aim was to define baseline qPCR
values for these bacterial species in a typical healthy
population of women not using hormonal contracep-
tion and without BV, as defined by the Nugent score,
and to describe any temporal variations over 3 men-
strual cycles [8,17]. Published data on how quickly the
composition of vaginal flora changes are scarce and
therefore interpretation of ‘normal’ versus ‘pathological’
in the context of a phase I clinical trial is difficult [18-
20]. We also wanted to compare the baseline values in
the “healthy population” with available data obtained
from a population of women deemed to be “at risk” of
STI and HIV on the basis of their attendance at a local
low threshold STI and voluntary HIV testing and coun-
seling clinicMethods
Clinical set up
We followed our usual strategy for the recruitment of a
classical ‘healthy population’ for phase I microbicide
trials [21]. Thirty women were enrolled and followed ap-
proximately nine weeks. They were aged between 18 and
35 years, were not using hormonal contraception, did
not have vaginal infections at screening, and had a regu-
lar menstrual cycle. Any kind of sexual activity was per-
mitted and condoms were provided. After screening, the
women received appointments for five follow up visits
that were planned on day 7 and 21 of the two next
cycles and on day 7 of the third cycle. At each visit the
women completed a written questionnaire about their
sexual activity during the previous 72 hours.
The second group of women had been recruited six
months earlier at a local STI clinic and HIV testing and
counseling centre. Women attending the clinic were
asked to participate in a study analysing the vaginal
microbiome before and after BV treatment. A total of 41
women were enrolled and vaginal samples were taken
and tested for STIs and BV on two occasions: at baseline
and approximately two weeks later. BV was defined on
the basis of a Nugent score of 7 or more and women
with BV were treated with a single dose of 2 gram oral
metronidazole.
A clinician collected two high vaginal specimens from
each woman during every visit, with flocked synthetic
swabs (COPAN innovation, Italy). A third vaginal speci-
men was collected from the healthy women for Prostate
Specific Antigen (PSA) testing. The swabs were stored at
2-8 °C and then transported within 12 hours to the la-
boratory, where they were stored dry at minus 20 °C
until testing.
Laboratory methods
DNA extraction
After thawing the swabs at room temperature for 30
minutes, 1200 μL diluted PBS [pH 7.4] (1:9, PBS:saline)
was added to the swabs and gently vortexed for at least
15 seconds. The eluates of both swabs were pooled and
a final volume of 2000 μL of specimen eluate was
obtained. After finalising the samples from the women
attending the STI clinic, we learned that DNA yield of
Gram positive microorganisms could be improved by
adding a lysis step prior to the extraction. This strategy
was then applied to the samples of the healthy women
and as a result DNA extraction methods differed be-
tween the two groups of women. An aliquot of 250 μL
eluate of the specimens collected from the healthy popu-
lation was processed using the easyMag (BioMérieux,
Marcy l’Etoile, France) after an initial lysing step with
mutanolysin (Sigma Aldrich, Bornem, Belgium) and pro-
teinase K (PK)(Qiagen, Venlo, the Netherlands). Briefly,
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and 250 μL mutanolysin/PK buffer was added to the pel-
let. After vortexing 2.5 μL mutanolysin (25U/μL) was
added and incubated for 15 min at 37 °C. Thereafter, a
volume of 12.5 μL PK (25 mg/mL) was added and incu-
bated for 15 min at 55 °C including vortexing every 5
minutes. Finally, 1750 μL of Nuclisens Easymag buffer
was added prior to the extraction, following the manu-
facturer’s instructions. For the specimens collected from
the clinic population, an aliquot of 500 μL was processed
according to the Boom extraction using the miniMAG
system (BioMérieux, Marcy l’Etoile, France) and accord-
ing to the manufacturer’s instructions.
Quantitative PCR
Quantitative PCR for total Lactobacillus species, L. cris-
patus, L. iners, L. jensenii, L. gasseri, L. vaginalis, G.
vaginalis, and A. vaginae were performed with the pri-
mers as described in Table 1. The primers were synthe-
sized by Eurogentec, Seraing, Belgium. The 25 μL PCR
mixture contained QuantiTect SYBR Green PCR (Qia-
gen, Venlo, the Netherlands) with the exception of the
PCR mixture for L. vaginalis which contained Thermo
Scientific Absolute SYBR Green Mix (ABgene, Epsom,
UK), 5 μL DNA extract, primers, and Milli-Q water. The
amplification reactions were performed using the Cor-
bett Life Science Rotor-Gene™ 6000 (Qiagen, Venlo, the
Netherlands) and the amplification programs as
described in Table 1. Each sample was run in duplicate.Table 1 Primers for Quantitative PCR
PCR Reference Primers
L. species Zariffard MR [28] F-LBF: 5′- ATGGAAGAACACCAGT
R- LBR: 5′- CAGCACTGAGAGGCGG
L. crispatus Byun R [29] LcrisF: 5′-AGCGAGCGGAACTAACAG
LcrisR : 5′-AGCTGATCATGCGATCT
L. gasseri Tamrakar R [30] LgassF: 5′-AGCGAGCTTGCCTAGATG
LgassR: 5′-TCTTTTAAACTCTAGACAT
L. iners De Backer E [31] InersFw: 5′-GTCTGCCTTGAAGAT
InersRev: 5′-ACAGTTGATAGGCAT
L. jensenii Tamrakar R [30] LjensF: 5′-AAGTCGAGCGAGCTTGCC
LjensR: 5′-CTTCTTTCATGCGAAAG
L. vaginalis In-house designed primers LV16s_23s_F: 5′-GCCTAACCATTTGG
LV16s_23s_R3: 5′-CGATGTGTAGGT
G. vaginalis Zariffard MR [28] F-GV1: 5′-TTACTGGTGTATCACTGT
R-GV3: 5′-CCGTCACAGGCTGAAC
A. vaginae De Backer E [31] ATOVAGRT3Fw: 5′-GGTGAAGCAGTGG
ATOVAGRT3Rev: 5′-ATTCGCTTCTGCTFor each of the organisms standard curves were con-
structed and included in each run. A total of 6 standards
were prepared by a tenfold dilution and within a range
of 102 copies/5 μL to 107 copies/5 μL. Reference strains
(L. crispatus (LMG 9479T), L. jensenii (LMG 6414T), L.
iners (LMG 18914 T), L. gasseri (LMG 9203T), L. vagina-
lis (LMGT 12891), G. vaginalis (LMG 7832 T), A. vagi-
nae (CCUG 38953)) were cultured on Columbia agar
(Beckton Dickinson, Le pont de Claix, France) supple-
mented with 5% Defibrinated Horse Blood (E&O labora-
tories Ltd, Burnhouse, Bonnybridge, Scotland) and
incubated in an anaerobic atmosphere (Anaerocult A,
Merck Chemicals, Darmstadt, Germany) for 24 hours at
35°C. A suspension was made in 400 μL molecular biol-
ogy water and DNA was extracted as described above.
The DNA concentration was determined by using the
Nanodrop ND-1000 (Nanodrop Technnologies, Wil-
mington, USA). The number of cells in each dilution
was calculated taking into account the genome size of
the bacterial species. The quantitative result obtained
with the qPCR was expressed in number of copies/5 μL
and was back calculated taking into account the total
specimen elute volume, the volume extracted, the DNA
extract volume obtained, and volume of DNA amplified.
Prostate specific antigen
The PSA testing was performed using the SeratecW PSA
semiquant assay (Seratec Diagnostica, Göttingen, Ger-
many). A volume of 500 μL of PSA buffer was added toTarget gene Cycling conditions Concentration
GGCG-3′ 16 S r RNA 15 min 95 °C,
(15 sec 95 °C, 45 sec 50 °C,
45 sec 72 °C) x37
150 nM
AAAC-3′
ATTTAC-3′ 16 S r RNA 15 min, 95 °C,
(15 sec 95 °C, 60 sec 60 °C,
20 sec 72 °C) x40
100 nM
GCTT-3′
AATTTG-3′ 16 S r RNA 15 min 95 °C,
(15 sec 95 °C, 60 sec 57 °C,
60 sec 65 °C) x40
200 nM
GCGTC-3′
CGG-3′ 16 S r RNA 15 min 95 °C,
(15 sec 95 °C, 55 sec 60 °C,
60 sec 65 °C) x35
200 nM
CATC-3′
TATAGA-3′ 16 S r RNA 15 min 95 °C,
(15 sec 95 °C, 55 sec 60 °C,
60 sec 72 °C) x40
300 nM
TAGC-3′
AGGG-3′ 16 S-23 S r RNA 15 min 95 °C,
(15 sec 95 °C, 30 sec 56 °C,
30 sec 72 °C)x37
200 nM
TTCCG-3′
AAGG-3′ 16 S r RNA 15 min 95 °C,
(45 sec 95 °C, 45 sec 55 °C,
45 sec 72 °C) x50
260 nM
AGT-3′
AAACACT-3′ 16 S r RNA 15 min 95 °C,
(20 sec 95 °C, 45 sec 60 °C,
45 sec 72 °C) x45
300 nM
CGCGCA-3′
Table 2 Baseline Characteristics of Study Populations
Healthy
Population
(N = 30)
Clinic
Populationa
(N= 41)
¹
Age (years) Mean (range) 27 (19–38) 27 (15–47)
²
Ethnicity N (%) Black 0 (0) 13 (32)
Caucasian 30 (100) 20 (49)
Asian 0 (0) 5 (12)
³
Contraception
N (%)
None 12 (40) 18 (46)
Combined pill 0 (0) 9 (23)
Intrauterine device 1 (3) 8 (21)
Implant 0 (0) 2 (5)
Condoms 17 (57) 2 (5)
Nugent score
0–3
30 (100%) 29 (71%)
4–6 0 (0%) 0 (0%)
7–10 0 (0%) 12 (29%)
¹ 5 missing values ² 3 missing values ³ 2 missing values.
a STI clinic and HIV testing and counseling centre.
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trifugation of 300 μL for 1 min at 13000 g, 200 μL of
supernatant was used for testing, following the manufac-
turer’s instructions.
Data analysis
Baseline characteristics were described using means
(ranges) and proportions. We analyzed changes in the
profile of the Lactobacillus species in the healthy popu-
lation by defining groups of women based on the con-
sistent presence (present in samples in at least 4 out of 5
visits) or absence of each Lactobacillus species. We
looked for any predictors of “consistently having a par-
ticular species” using logistic regression and predictors
of the Lactobacillus counts in these women using linear
mixed effects models. We compared the presence of in-
dividual microbiome species at the baseline visit between
‘healthy population (HP)’ women and ‘clinic population
(CP)’ using logistic regression models. We then com-
pared the counts between CP women with (CPBVpos)
and without (CPBVneg) bacterial vaginosis using Wil-
coxon Rank Sum test. No comparisons in counts be-
tween HP and CP species were performed due to the
differences in nucleic acid extraction techniques. Using
the presence or absence of each of the microbiome spe-
cies, we divided the study population (CP and HP com-
bined) in groups with Latent Class Analysis, a statistical
technique related to cluster analysis, and assessed the
distribution of the different groups in the women by BV
status and ethnic origin [22]. We assessed the relation-
ship between Nugent scores and the presence of each of
the microbiome species in the CP population using scat-
ter plots, and we added a trend-line and a Spearman
correlation coefficient R.
Ethical approval
IRB approval was obtained from the Institute of Tropical
Medicine and from the Ethics Committee at the Univer-
sity Hospital of Antwerp. All study participants gave
their written informed consent.
Results
Study populations
Baseline characteristics of the two study populations are
presented in Table 2. All women recruited into the HP
group were Caucasian. They were all asymptomatic at
baseline and no diagnosis of BV was made in this group,
neither at baseline nor during any of the follow up visits.
Five of the 30 HP women (12.5%) had a sexual prefer-
ence for the same gender and four of them were cur-
rently sexually active. Of the remaining 25 heterosexual
women, 17 (68%) were currently sexually active. Follow
up of the HP women was high, with 28 out of 30 women
completing all visits. Prostate specific antigen (PSA) wasdetected on 12 occasions in 7 women. Of the women
recruited at the clinic (CP), 49% were Caucasian, 32%
were of black African origin and living in Belgium, 12%
of Asian origin, and for 7%, ethnicity was not recorded.
50% percent of the women at the clinic presented with a
complaint of vaginal discharge at baseline and 29% had
BV as assessed by Nugent score. The presence of self-
reported smelly discharge was significantly associated
with BV (p = 0.001) but no association was seen between
BV and ethnicity.Changes over time in species presence and species
counts in the healthy women
In general, the presence or absence of a particular Lacto-
bacillus species in the HP remained constant throughout
the study visits (Figure 1). L. crispatus, L. iners, L. jense-
nii, and L. gasseri were present at least once in 90%,
77%, 73%, and 70% of women, respectively. G. vaginalis
was present at least at one visit in 47% of women and A.
vaginae in 20% of women. L. crispatus, L. iners, L. jense-
nii, and L. gasseri were consistently present (minimum 4
out of 5 visits) in 60%, 67%, 63%, and 67% of women.
We categorised the latter group of women, “women with
consistent Lactos”. We explored sexual preference;
current sexual activity; presence of PSA; time in the
menstrual cycle; and age as predictors for being a
“women with consistent Lactos”. None of these factors
were found to be associated with the consistent presence
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Figure 1 Presence of species by day in the menstrual cycle. cps/mL: copies/mL.
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23% of women and A. vaginae in 7% of women. Risk fac-
tor analysis was not performed due to low numbers.
Longitudinal analysis of the “women with consistent
Lactos” showed that L. crispatus counts were 0.22 log
higher (p< 0.001) and L. iners counts were 0.83 log
lower (p< 0.001) in the post-ovulatory phase of the
cycle. Furthermore, L. crispatus counts were decreased
by 0.42 log after intercourse (PSA present) (p = 0.002),
while those of L. iners (+0.73 log, p = 0.033) and of L.
gasseri (+0.59 log, p = 0.058) were increased.
Two women developed intermediate Nugent scores at
visit 4 (6 and 4), while their scores at the other visitswere 0. The bacterial cell counts by visit for these two
women are shown in Figure 2. In both of these women,
the increase in Nugent score coincided with an increase
in L. iners counts. In the first woman, in whom G. vagi-
nalis was present throughout the study, A. vaginae
appeared on the same day as the raised Nugent score.
This woman complained of a vaginal itch and dysuria,
had a white watery discharge on examination, and a
raised pH of 6.1. In the second woman, G. vaginalis
appeared together with the elevated Nugent score, while
A. vaginae remained absent. This woman had a positive
PSA test and also had a new sexual partner since the
previous visit.
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Figure 2 Presence of species by day in the menstrual cycle for two women developing an elevated Nugent score. cps/mL: copies/mL.
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women at risk of STIs
The Lactobacillusspecies were present at baseline in all
women. The frequencies of the presence of individual
microbiome species are summarized in Table 3, which
also presents a pairwise comparison between the HP, the
CP without BV (CPBVneg), and the CP with BV
(CPBVpos). L. crispatus and L. vaginalis were signifi-
cantly more present in HP women and CPBVneg women
compared to the CPBVpos women. L. gasseri was more
often present in HP women compared to the CPBVneg
women (p = 0.004), but the differences within the CP
were not significant. L. iners was less frequently present
in the HP compared to the other 2 groups but this was
not statistically significant. G. vaginalis was significantly
more frequently present in CP women than in HP
women. A. vaginae was significantly more present in
CPBVpos compared to HP women and CPBVneg women.Table 3 Presence of species at baseline
Healthy population Clinic populationa
BV= 0 BV= 0 BV= 1
N= 30 N= 29 N= 12
N (%) N (%) N (%)
L. crispatus 23 (77) 23 (79) 5 (42)
L. iners 20 (67) 25 (86) 10 (83)
L. jensenii 17 (57) 15 (52) 3 (25)
L. gasseri 19 (63) 7 (24) 1 (8)
L. vaginalis 22 (73) 18 (62) 1 (8)
G. vaginalis 10 (33) 20 (69) 12 (100)
A. vaginae 4 (13) 8 (28) 11 (92)
All P-values from Fisher’s exact test; HP =Healthy population; CPBVneg =Clinic popu
=versus; BV = 0 or Nugent scoring 0–3; BV = 1 or Nugent scoring 7–10.
a STI clinic and HIV testing and counseling centre.When analyzing the presence and absence of micro-
flora species at baseline using Latent Class Analysis
(LCA) and combining the ‘healthy population’ and the
‘clinic population’, 3 groups were identified (Table 4).
The first group is characterized by the predominance of
L. crispatus, L. iners, L. jensenii, and L. vaginalis and a
low frequency (<30% of women) of L. gasseri and A.
vaginae. This group is mostly prevalent in the women
with a normal Nugent score, regardless of whether they
belonged to the HP group or to the CP group. The sec-
ond group is mainly characterized by the presence of L.
gasseri and L. vaginalis and by a less frequent presence
of L. jensenii, L. crispatus, or L. iners. This group is
mostly prevalent in the Caucasian women, HP women,
as well as CP women without BV. The third group is
characterized by the presence of G. vaginalis and A.
vaginae and the absence of Lactobacillus species, except
for L. iners. Most women with BV belong to this group,Pairwise comparisons
HP vs. CPBVneg HP vs. CPBVpos CPBVneg vs. CPBVpos
p-value p-value p-value
1.000 0.067 0.029
0.125 0.453 1.000
0.796 0.091 0.171
0.004 0.002 0.214
0.421 <0.001 0.002
0.009 <0.001 0.039
0.209 <0.001 <0.001
lation women without BV; CPBVpos = Clinic population women with BV; vs.
Table 4 Latent class analysis for the presence of species
at baseline
a. Probability (%) of species presence in each of the latent classes
Group 1 Group 2 Group 3
L. crispatus 90 63 50
L. iners 88 43 89
L. jensenii 84 24 21
L. gasseri 29 87 6
L. vaginalis 79 70 16
G. vaginalis 50 36 95
A. vaginae 19 15 72
b. Prevalence (%) of the three latent classes by risk population/
BV class
Group 1 Group 2 Group 3
HP 47 47 6
CP BV neg - Caucasian 64 29 7
CP BV neg - other 35 11 54
CP BV pos 9 10 81
HP=Healthy population; CPBVneg =Clinic population women without BV;
CPBVpos = Clinic population women with BV.
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0–3; BV = 1 or Nugent scoring 7–10.
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women without BV.
The qPCR counts are graphically represented in Fig-
ure 3. Figure 3 panel B, illustrating the CPBVneg and
CPBVpos counts, shows that counts for overall Lactoba-
cillus species (p< 0.001), L. crispatus (p< 0.001) and L.
vaginalis (p = 0.005) were significantly higher for women
without BV compared to those with BV. The counts for
G. vaginalis (p< 0.001) and A. vaginae (p< 0.001) were,
on the contrary, significantly lower in women without
BV compared to those with BV. There were no signifi-
cant differences in the amount of L. iners, L. gasseri, and
L. jensenii related to BV status in the CP.
The correlation of the qPCR log counts of the individ-
ual species of the CP population with the Nugent scores
is presented in Figure 4. Overall lactobacillus counts
(R =−0.553) and counts of L. crispatus (R =−0.411) and
L. vaginalis (R =−0.421) decreased with increasing
Nugent scores. Counts of G. vaginalis (R = 0.505) and A.
vaginae (R = 0.606) increased with increasing Nugent
scores. Correlations between Nugent scores and counts
of L. iners (R =−0.062), L. jensenii (R =−0.192), and L.
gasseri (R =−0.162) were low.BV: − + − + − + − + − + − + − + − +
Lacto crisp iners jens gass vag Gard Ato
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Figure 4 Correlation of the qPCR log counts data with the individual species by Nugent score. cps/mL: copies/mL.
Jespers et al. BMC Microbiology 2012, 12:83 Page 8 of 10
http://www.biomedcentral.com/1471-2180/12/83Discussion
The data from our population of healthy women shows
that the composition of the vaginal microbiome over
time (5 visits) is very stable. A raised Nugent score (4
and 6) was only recorded on two occasions and we can
thus conclude that the microbiome of this population
represents a ‘healthy normal flora’.
The increase in L. crispatus and the decrease in L.
iners in the post-ovulatory phase of the menstrual cycle
seems in accord with the results of Srinivasan et al.,
showing a decrease of L. crispatus (−0.6 log) during
menstruation, followed by a reconstitution of L. crispa-
tus after menses [18]. The same authors also noticed
that G. vaginalis was present for all the women at one
point in the study, albeit at low numbers. We found that
in 23% of the healthy women, G. vaginalis was consist-
ently present. It is interesting to note that in the women
from the HP with intermediate Nugent scores, the L.
iners counts had increased. In the woman with symp-
toms, this increase was accompanied by a rise in G. vagi-
nalis and in the woman with a new sex partner the
numbers of A. vaginae were raised. Intermediate Nugent
scores have been associated with frequent presence of G.
vaginalis (70% - 92%) and A. vaginae (78% - 84%)
[23,24]. The acquisition of a new sex partner may well
be an important risk factor for BV. Larsson et al. found
that relapse of BV in a Swedish population was highly
associated (OR 9.3) with the acquisition of a new sexpartner and Walker et al. saw that incident BV in Aus-
tralian young women was associated with increasing
numbers of sex partners [23,25].
Using LCA, we identified 2 types of ‘normal flora’ and
one ‘BV type flora’. The first group of ‘normal flora’ was
characterized by the predominance of a combination of
four Lactobacillus species excluding L. gasseri, whereas
in the second group L. gasseri and L. vaginalis predomi-
nated. The third group, associated with BV, was domi-
nated by A. vaginae, G. vaginalis, and L. iners. Group 1
in our study was similar to community groups I, III, and
V as defined by Ravel et al.; group 2 corresponded to
community group II, and group 3 was similar to com-
munity group IV [14]. All 3 microbiome groups were
represented in the different groups of women (HP, CP
without BV, and CP with BV). However, among the
women without BV there appeared to be large differ-
ences in the relative distribution of the different LCA
groups according to ethnicity. Caucasian women mostly
belonged to group 1 or 2, while African/Asian women
mostly belonged to group 3. We should therefore not as-
sume that all microbiomes with low Nugent scores are
similar. Our data are in line with the findings of Ravel
et al., who reported that healthy African/Asian women
have a higher probability of belonging to group 3, the
‘BV type flora’ group [16,26].
The results of this study are in line with published lit-
erature showing that L. crispatus is consistently present
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ecosystem as defined by the Nugent score (0–3) whereas
G. vaginalis and A. vaginae are highly present in women
with BV [11,24]. We explored the correlation of specific
species with the individual Nugent scores and showed
that L. vaginalis (R =−0.421) shows the same inverse
correlation as L. crispatus (R =−0.411) with increasing
Nugent scores. A low correlation was seen for L. gasseri
and the Nugent score and this may reflect the confound-
ing effect of ethnicity. This study is among the first to
show that L. vaginalis is highly represented in the nor-
mal healthy vaginal flora with typical counts of 106 cop-
ies/mL. L. crispatus, L. jensenii, L. gasseri, and L.
vaginalis were less frequently present in women at
higher risk of an STI, while L. iners remained present.
The fact that L. iners is always present, even when A.
vaginae and G. vaginalis are present, makes us wonder
whether L. iners increases susceptibility to BV. This
would be in line with the findings of Antonio et al. who
recently demonstrated that only L. crispatus had a pro-
tective effect against acquisition of BV [27].
We observed higher bacterial counts with the com-
bined lysis-Boom extraction compared to the Boom ex-
traction alone (results not shown). The extra lysis step
particularly improved the efficiency of the DNA extrac-
tion from Gram positive microorganisms. As a result of
these different methods of extraction, we were unable
to directly compare the quantitative counts from the
HP and CP group (Figure 3) and this represents a
weakness of this study. This shortcoming illustrates that
results across studies can only be compared after ascer-
taining that laboratory methods are consistent [28,29].
Another limitation of this study is the small sample size
and limited statistical power. Furthermore, the two
groups of women differed in aspects such as contracep-
tion, the number of follow up visits and time points in
the cycle that were sampled. Finally, our definition of
bacterial vaginosis was based on the Nugent score, and
although this scoring system is considered to be the
gold standard for research, we recognize it is not
perfect.Conclusion
We have shown that qPCR can be used to quantify and
describe the bacterial species associated with the non-
BV vaginal microbiome. We have also shown that risk
status and ethnicity can also impact upon the number
and type of organisms present and therefore also need
to be taken into account. The analysis of seven indicator
organisms by qPCR is a feasible approach for the assess-
ment of the vaginal microbiome and could be used for
analyzing the composition of the microbiome during the
safety assessments of vaginal products.Acknowledgements
This work was supported by the European Commission [European
Microbicides Project 503558, EUROPRISE and CHAARM 242135] and by the
Foundation Dormeur, Switzerland. We are grateful to the participants and
the study’s physicians, Dr. Ilse Collier, Dr. Christiane Van Ghijseghem and Dr.
Kristien Wouters.
Author details
1Department of Public Health, ITM HIV/AIDS Centre, Institute of Tropical
Medicine, Nationalestraat 155, 2000, Antwerp, Belgium. 2Clinical Trials Unit,
Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.
3HIV/STI Reference Laboratory, Institute of Tropical Medicine, Nationalestraat
155, 2000, Antwerp, Belgium. 4Faculty of Medicine and Health Sciences,
Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.Authors’ contributions
VJ, TC, and AB conceived and designed the study. VJ wrote the first version
of the manuscript. JM provided statistical support for the design of the study
and performed the statistical analyses. TC supervised the laboratory analytical
procedures and validated the laboratory results. TC, HS, SA and RV set up
and carried out the qPCRs. SP and LH participated in the design and clinical
coordination of the study. All authors contributed to the editing, and
approved the final paper.
Received: 13 October 2011 Accepted: 30 May 2012
Published: 30 May 2012References
1. Myer L, Kuhn L, Stein ZA, Wright TC Jr, Denny L: Intravaginal practices,
bacterial vaginosis, and women’s susceptibility to HIV infection:
epidemiological evidence and biological mechanisms. Lancet Infect Dis
2005, 5:786–794.
2. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP,
Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG: Bacterial vaginosis
and disturbances of vaginal flora: association with increased acquisition
of HIV. AIDS 1998, 12:1699–1706.
3. van de Wijgert JH, Morrison CS, Brown J, Kwok C, Van Der PB, Chipato T,
Byamugisha JK, Padian N, Salata RA: Disentangling contributions of
reproductive tract infections to HIV acquisition in African Women. Sex
Transm Dis 2009, 36:357–364.
4. Mirmonsef P, Gilbert D, Zariffard MR, Hamaker BR, Kaur A, Landay AL, Spear
GT: The effects of commensal bacteria on innate immune responses in
the female genital tract. Am J Reprod Immunol 2011, 65:190–195.
5. Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA: The normal
vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in
pregnant women. Clin Infect Dis 1993, 16(Suppl 4):S273–S281.
6. Klebanoff SJ, Coombs RW: Viricidal effect of Lactobacillus acidophilus on
human immunodeficiency virus type 1: possible role in heterosexual
transmission. J Exp Med 1991, 174:289–292.
7. Cherpes TL, Hillier SL, Meyn LA, Busch JL, Krohn MA: A delicate balance:
risk factors for acquisition of bacterial vaginosis include sexual activity,
absence of hydrogen peroxide-producing lactobacilli, black race, and
positive herpes simplex virus type 2 serology. Sex Transm Dis 2008, 35:
78–83.
8. Nugent R, Krohn M, Hillier S: Reliability of diagnosing bacterial vaginosis is
improved by a standardized method of gram stain interpretation. J Clin
Microbiol 1991, 29:297–301.
9. Hugenholtz P, Goebel BM, Pace NR: Impact of culture-independent
studies on the emerging phylogenetic view of bacterial diversity.
J Bacteriol 1998, 180:4765–4774.
10. Sha BE, Chen HY, Wang QJ, Zariffard MR, Cohen MH, Spear GT: Utility of
Amsel criteria, Nugent score, and quantitative PCR for Gardnerella
vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of
bacterial vaginosis in human immunodeficiency virus-infected women.
J Clin Microbiol 2005, 43:4607–4612.
11. Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Delanghe J, Van Simaey
L, De Ganck C, Temmerman M, Vaneechoutte M: Cloning of 16 S rRNA
genes amplified from normal and disturbed vaginal microflora suggests
a strong association between Atopobium vaginae, Gardnerella vaginalis
and bacterial vaginosis. BMC Microbiol 2004, 4:16.
Jespers et al. BMC Microbiology 2012, 12:83 Page 10 of 10
http://www.biomedcentral.com/1471-2180/12/8312. Fredricks DN, Fiedler TL, Thomas KK, Oakley BB, Marrazzo JM: Targeted PCR
for detection of vaginal bacteria associated with bacterial vaginosis.
J Clin Microbiol 2007, 45:3270–3276.
13. Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J,
Gloor GB, Reid G: Deep sequencing of the vaginal microbiota of women
with HIV. PLoS One 2010, 5:e12078.
14. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S,
Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney
LJ: Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci
USA 2011, 108(Suppl 1):4680–4687.
15. Spear GT, Gilbert D, Landay AL, Zariffard R, French AL, Patel P, Gillevet PM:
Pyrosequencing of the genital microbiotas of HIV-seropositive and
-seronegative women reveals Lactobacillus iners as the predominant
Lactobacillus Species. Appl Environ Microbiol 2011, 77:378–381.
16. Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P, Foster JA,
Forney LJ: Differences in the composition of vaginal microbial
communities found in healthy Caucasian and black women. ISME J 2007,
1:121–133.
17. Lamont R, Sobel J, Akins R, Hassan S, Chaiworapongsa T, Kusanovic J,
Romero R: The vaginal microbiome: new information about genital
tract flora using molecular based techniques. BJOG 2011, 118:
533–549.
18. Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, Marrazzo
JM, Fredricks DN: Temporal variability of human vaginal bacteria and
relationship with bacterial vaginosis. PLoS One 2010, 5:e10197.
19. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M,
Vaneechoutte M: Longitudinal analysis of the vaginal microflora in
pregnancy suggests that L. crispatus promotes the stability of the
normal vaginal microflora and that L. gasseri and/or L. iners are more
conducive to the occurrence of abnormal vaginal microflora. BMC
Microbiol 2009, 9:116.
20. Santiago GL, Cools P, Verstraelen H, Trog M, Missine G, El Aila N, Verhelst R,
Tency I, Claeys G, Temmerman M, Vaneechoutte M: Longitudinal study of
the dynamics of vaginal microflora during two consecutive menstrual
cycles. PLoS One 2011, 6:e28180.
21. Jespers VA, Van Roey JM, Beets GI, Buve AM: Dose-ranging phase 1 study
of TMC120, a promising vaginal microbicide, in HIV-negative and
HIV-positive female volunteers. J Acquir Immune Defic Syndr 2007, 44:
154–158.
22. McCutcheon AL: Latent Class Analysis. Quantitative Applications in the Social
Sciences Series N° 64. Thousand Oaks: Sage Publication; 1987. edition.
23. Larsson PG, Brandsborg E, Forsum U, Pendharkar S, Krogh-Andersen K, Nasic
S, Hammarstrom L, Marcotte H: Extended antimicrobial treatment of
bacterial vaginosis combined with human lactobacilli to find the best
treatment and minimize the risk of relapses. BMC Infect Dis 2011,
11:223.
24. Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D: Molecular
quantification of Gardnerella vaginalis and Atopobium vaginae loads to
predict bacterial vaginosis. Clin Infect Dis 2008, 47:33–43.
25. Walker J, Hocking J, Fairley C, Tabrizi S, Chen M, Bowden F, Gunn J,
Donovan B, Kaldor J, Bradshaw C: The prevalence and incidence of
bacterial vaginosis in a cohort of young Australian women. Sex Transm
Infect 2011, Vol 87:Suppl 1.
26. Zhou X, Hansmann MA, Davis CC, Suzuki H, Brown CJ, Schutte U, Pierson
JD, Forney LJ: The vaginal bacterial communities of Japanese women
resemble those of women in other racial groups. FEMS Immunol Med
Microbiol 2010, 58:169–181.
27. Antonio M, Petrina M, Meyn L, Hillier S: Lactobacillus crispatus colonisation
reduces risk of bacterial vaginosis (BV) acquisition. Sex Transm Dis 2011,
Vol 87(Suppl 1):A304–A305.
28. Zariffard MR, Saifuddin M, Sha BE, Spear GT: Detection of bacterial
vaginosis-related organisms by real-time PCR for Lactobacilli, Gardnerella
vaginalis and Mycoplasma hominis. FEMS Immunol Med Microbiol 2002,
34:277–281.
29. Byun R, Nadkarni MA, Chhour KL, Martin FE, Jacques NA, Hunter N:
Quantitative analysis of diverse Lactobacillus species present in
advanced dental caries. J Clin Microbiol 2004, 42:3128–3136.
30. Tamrakar R, Yamada T, Furuta I, Cho K, Morikawa M, Yamada H, Sakuragi N,
Minakami H: Association between Lactobacillus species and bacterial
vaginosis-related bacteria, and bacterial vaginosis scores in pregnant
Japanese women. BMC Infect Dis 2007, 7:128.31. De Backer E, Verhelst R, Verstraelen H, Alqumber MA, Burton JP, Tagg JR,
Temmerman M, Vaneechoutte M: Quantitative determination by real-time
PCR of four vaginal Lactobacillus species. Gardnerella vaginalis and
Atopobium vaginae indicates an inverse relationship between L. gasseri
and L. iners. BMC Microbiol 2007, 7:115.
doi:10.1186/1471-2180-12-83
Cite this article as: Jespers et al.: Quantification of bacterial species of
the vaginal microbiome in different groups of women, using nucleic
acid amplification tests. BMC Microbiology 2012 12:83.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
